Abstract B052: Plasma proteomic biomarkers reveal biological insights about the tumor microenvironment in melanoma patients after PD1 blockade
Abstract This abstract is being presented as a short talk in the scientific program. A full abstract is printed in the Proffered Abstracts section (PR018) of the Conference Program/Proceedings. Citation Format: Samuel J. Wright, Izabella Zamora, Milan Parikh, Deepika Yeramosu, Lynn Bi, Sarah Kang, Marijana Rucevic, Moshe Sade-Feldman, Baolin Liu, Ngan Nguyen, Jamey Guess, Alexis Schneider, David Lieb, Elliot Woods, William Michaud, Aleigha R. Lawless, Tatyana Sharova, Gyulnara Kasumova, Michelle S. Kim, Ryan J. Park, Russell W. Jenkins, Samuel J. Klempner, Ryan J. Sullivan, Keith T. Flaherty, Nir Hacohen, Genevieve M. Boland, Arnav Mehta. Plasma proteomic biomarkers reveal biological insights about the tumor microenvironment in melanoma patients after PD1 blockade [abstract]. In: Proceedings of the AACR Special Conference: Liquid Biopsy: From Discovery to Clinical Implementation; 2024 Nov 13-16; San Diego, CA. Philadelphia (PA): AACR; Clin Cancer Res 2024;30(21_Suppl):Abstract nr B052.
Authors
- Arnav Mehta (ORCID: https://orcid.org/0000-0002-0313-2848)
- Marijana Ručević (ORCID: https://orcid.org/0000-0003-1003-2666)
- Ryan J. Sullivan (ORCID: https://orcid.org/0000-0001-5344-6645)
- Genevieve Marie Boland (ORCID: https://orcid.org/0000-0002-7522-6173)
- Samuel J. Wright (ORCID: https://orcid.org/0009-0006-4892-5338)
- Alexis M. Schneider (ORCID: https://orcid.org/0000-0002-2158-6915)
- Keith T. Flaherty (ORCID: https://orcid.org/0000-0002-3402-0478)
- Tatyana Sharova (ORCID: https://orcid.org/0000-0003-2123-3906)
- Gyulnara G. Kasumova
- Russell W. Jenkins (ORCID: https://orcid.org/0000-0001-6110-2148)
- Ngan Luu-Thuy Nguyen (ORCID: https://orcid.org/0000-0003-3931-849X)
- Elliot C. Woods (ORCID: https://orcid.org/0000-0003-2920-8334)
- Milan Parikh (ORCID: https://orcid.org/0000-0003-1336-7883)
- Nir Hacohen (ORCID: https://orcid.org/0000-0002-2349-2656)
- Deepika Yeramosu (ORCID: https://orcid.org/0000-0003-3963-8995)
- Lynn Bi (ORCID: https://orcid.org/0000-0002-8955-8208)
- Moshe Sade-Feldman (ORCID: https://orcid.org/0000-0002-0022-0287)
- Michelle S. Kim (ORCID: https://orcid.org/0000-0003-2008-4603)
- D. Lieb
- Samuel Jacob Klempner (ORCID: https://orcid.org/0000-0002-4062-0808)
- Jamey Guess
- Izabella Zamora
- Ryan Jin-hyung Park (ORCID: https://orcid.org/0000-0003-4725-2937)
- Aleigha Lawless (ORCID: https://orcid.org/0009-0009-3861-3164)
- William A. Michaud (ORCID: https://orcid.org/0000-0002-3664-2094)
- Baolin Liu (ORCID: https://orcid.org/0000-0001-8466-3837)
- Sarah Kang (ORCID: https://orcid.org/0009-0006-2822-3806)
Institutions
- Broad Institute (US)
- The University of Texas MD Anderson Cancer Center (US)
- Harvard University (US)
- University of California, San Francisco (US)
- Massachusetts General Hospital (US)
- Abterra Biosciences (United States) (US)
Publication Details
- Journal
- Clinical Cancer Research
- Published
- 2024-11-13
- DOI
- https://doi.org/10.1158/1557-3265.liqbiop24-b052
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00